Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy. Dendreon’s flagship product, PROVENGE (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells. More than 40,000 men with advanced prostate cancer have been prescribed PROVENGE in the U.S. since 2010. Dendreon also is evaluating the use of PROVENGE in early-stage prostate cancer, with the hope of curing more men of the disease. Dendreon is headquartered in Seal Beach, Calif.
Company Details
- Employees
- 628
- Founded
- -
- Address
- 1700 Saturn Way, Seal Beach,ca 90740,united States
- Phone
- (877) 256-4545
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- dendreon.com
- Keywords
- Oncology, Cancer Treatment, Immunotherapy, Cellular Immunotherapy, Urology, CMO, Contract Manufacturing.
- HQ
- Seal Beach , CA
Dendreon Questions
Dendreon's helpline number is (877) 256-4545
Dendreon's website is dendreon.com
Dendreon's LinkedIn profile is https://www.linkedin.com/company/dendreon
Dendreon has
628 employees.
View email and phone details for 628
employees at Dendreon.
Dendreon's industry is
Biotechnology Research
Dendreon's top competitors are
Bristol Myers Squibb,
Amgen,
Regeneron,
Novartis,
Abbvie,
Gilead Sciences,
Sanofi,
Pfizer,
Kite Pharma,
Vertex Pharmaceuticals.
Dendreon's categories are Biotechnology Research
Dendreon's founding year is 1992
